EN2 and glioblastoma: We found that after knocking down TCF4 in GBM cells, the expression level of EN2 observably decreased by qRT‐PCR; however, the expression level of EN2 showed no biological differences after knocking down TCF3, TEF1, or TCF1 (Figures 6C and S3B).